CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy

Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025

/C O R R E C T I O N -- Dynavax Technologies/

Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Big Ideas, Global Reach SBA Honors Eventgroove with Exporter of the Year Award

Anivive's Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025

Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025

Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results

SystImmune, Inc. to Present Updated izalontamab brengitecan (iza-bren) Data in Locally Advanced or Metastatic Breast Cancer at ESMO Breast 2025

Minghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater China

Vantage Foundation Partners with Hands of Hope Laos to Empower Deaf Youth Through Inclusive Education

Palatin Technologies Announces Closing of Reduced Public Offering

Envision Unveils 2025 Net Zero Report at Smarter E Europe, Celebrates Third Year of Carbon Neutrality

SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER

Palatin Presents Breakthrough Symptom Resolution Data from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease at ARVO 2025

BioLife Solutions Updates Earnings Call Information

Nektar Therapeutics Reports First Quarter 2025 Financial Results

Spyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

TransMedics Reports First Quarter 2025 Financial Results

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

Avidity Biosciences Reports First Quarter 2025 Financial Results and Recent Highlights

SARC Launching Expanded Sarcoma Centers Directory Resource--Hear More at the Upcoming SARC Semiannual Meeting in Chicago

ADAR1 Capital Management Issues Open Letter to Keros Therapeutics Stockholders

Houston Biomanufacturing Accelerator Partners with Pilot Facility to Expand Lab and Production Capacity

Cellipont Bioservices and Optieum Biotechnologies Partner to Advance cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma

DNV recognized as a Notified Body for Certification under In Vitro Diagnostic Regulation (IVDR)

Phosphorex, NOF CORPORATION, NeoSome Life Sciences, NanoImaging Services, and Envol Biomedical Unite to Form the LNP Alliance--Accelerating Lipid Nanoparticle Drug Development

mRNA at a Crossroads: Transformative Medical Breakthroughs Threatened by Policy Uncertainty

TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported

Ratio Therapeutics to Establish New Radiopharmaceutical Manufacturing Facility

ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025

Peptone Establishes Strategic Partnership with Evotec to Selectively Target Intrinsically Disordered Proteins (IDPs) and Advance Small-Molecule Therapeutics at Scale

Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook

Caris Life Sciences Appoints Eric Matthews as Chief Business Officer, Biopharma Business Development

Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain

NextGen Jane Awarded Second NIH Grant For The Evaluation of a Non-Invasive Endometriosis Diagnostic

Marengo Doses First Patient in STARt-002 Clinical Trial Evaluating First-in-Class Dual T Cell Agonist, Invikafusp Alfa in Combination with TROP2-directed ADC Trodelvy® in Metastatic Breast Cancer

Penetrium™ Breaks Oncology Barriers: The Solution to Cold Tumors and Metastatic Cancer Unveiled at AACR 2025

SCG Announces Late-Breaking Clinical Data of SCG101 in HBV-Related Hepatocellular Carcinoma Presented at EASL 2025

Palatin Technologies Announces Transition to OTC Pink Following NYSE American Delisting Notice

Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 ENSURE Study at EASL Congress 2025, Suggesting BRII-179's Role in Advancing Higher HBsAg Loss

SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit

Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy

TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

AusperBio Presents Interim Phase IIb AHB-137 Clinical Data in a Late-Breaking Abstract at EASL™ Congress 2025

Apertura Gene Therapy Showcases the Progress of its Novel Human Transferrin Receptor AAV Capsid, TfR1 CapX, and Preclinical Programs for Tuberous Sclerosis Complex (TSC) at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson's Disease

IDBS Unveils Key Insights from Latest Survey on Lab Data Management in BioPharma

Geneseeq Unveils Groundbreaking Blood Test for Early Detection of Pancreatic Cancer

Eurofins Viracor Revolutionizes Respiratory Diagnostics with New BAL Specimen Type for NeXGen® Fungal / AFB NGS Assay

Inari Welcomes Agriculture Veteran Lisa Nunez Safarian as Board Director

Michigan Ross Executive Education Launches the Board Director Program in Collaboration with Emeritus

Hanx Biopharmaceuticals, Ltd. Showcases Five Innovative Cancer Therapies at 2025 AACR Annual Meeting

Alafair Biosciences Ranked #2 on the 2025 Longhorn 100 List of Fastest-Growing Longhorn-Led Businesses

FDA Grants Orphan Drug & Rare Pediatric Disease Designations to Infinant Health for NEC

Altesa BioSciences Details Positive Topline Vapendavir Results from Phase 2 Placebo-Controlled Rhinovirus Challenge Study in COPD Patients

Amplifica to Present Positive Clinical Outcomes for AMP-303 at the Society for Investigative Dermatology Annual Meeting

Connext Successfully Completes Dose Escalation Part of CNT201 Phase 1/2 Clinical Trial for Dupuytren's Contracture

Eirion Therapeutics to Present at the Society for Investigative Dermatology 2025 Annual Meeting

Bionova Scientific Licenses ATUM's Proprietary Transposon-Based Gene Delivery Technology to Accelerate & De-Risk Cell Line Development

Minaris Advanced Therapies launches as the leading global partner dedicated to cell therapy development, manufacturing, and testing

Palatin Expects $11.5 Million Financing to Cure NYSE American Delisting Notice

Aspen Neuroscience to Present at the International Society for Gene & Cell Therapy (ISCT) Annual Meeting

Invaio Sciences, a Flagship Pioneering Company, Appoints Magalie Guilhabert as Chief Science Officer

BioVaxys and Sona Nanotech Enter Research Collaboration

Manulife Releases 2024 Sustainability Report and Public Accountability Statement

Palatin Technologies Announces Pricing of up to $23 Million Public Offering

Novavax to Participate in BofA Securities 2025 Health Care Conference

ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets

PAQ Therapeutics Appoints Andrew Krivoshik, MD, PhD, as Chief Medical Officer, Announces Addition of Eric Rubin, MD, and Piro Lito MD, PhD, to Advisory Board

PAQ Therapeutics Announces $39 Million Series B Financing and Initiates Phase 1 Trial to Advance Novel Approach Addressing KRAS-Driven Cancers with High Unmet Need

Inductive Bio Raises $25M Series A to Transform Small Molecule Drug Discovery with Industry-Wide AI Platform

Viatris Announces Quarterly Dividend

Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025

Gardin Raises $4.5M to Advance Precision Agriculture with Breakthrough Photosynthesis Sensor & AI Platform to Monitor Greenhouse Crop Health at Scale, in Real Time

The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China

CIMC Modular Building Systems Triumphs with Dual International Awards at 2025 World of Modular Conference

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

Adcentrx Therapeutics Granted Fast Track Designation for ADRX-0706 Nectin-4 ADC for the Treatment of Advanced Cervical Cancer

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Perfuse Therapeutics Announces Positive Results from the Completed Phase 1/2a Clinical Trial of PER-001 Intravitreal Implant in Patients with Glaucoma

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update

Neurocrine Biosciences to Present at Upcoming Investor Conferences in May

Plasmidsaurus Opens 10th Global Lab in Singapore, Scaling to Meet the Demand for Cutting-Edge Sequencing Around the World

Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

Specific Biologics Inc. to Present Dualase® Genome Editing for the Precise Removal of Pathogenic Repeats in Repeat Expansion Disorders at the 28th Annual American Society for Gene and Cell Therapy Meeting

Solvias to Speak at ASGCT 2025 Highlighting Safer Gene Therapy Development

Prometheus Hyperscale, PureWest Energy and Frontier Infrastructure to Enable Zero-Carbon Power Solution for Flagship Wyoming Data Center

Helio Genomics Presents Three Abstracts on Early Cancer Detection with a Blood-Based Test at the 2025 Digestive Disease Week in San Diego

Avidity Biosciences to Participate in Upcoming Investor Conference

Volta Labs, Inc. and Hartwig Medical Foundation Collaborate to Advance Oncological Discoveries with the Callisto™ Sample Prep System

GRIN Therapeutics Receives Positive Opinion for EU Orphan Designation for Radiprodil for Treatment of GRIN-Related Neurodevelopmental Disorder

Curis Provides First Quarter 2025 Business Update